Sílvia Beà, winner of the CIBERONC “Award for Best Female Researcher”
Beà, a researcher of the IDIBAPS group Molecular pathology in lymphoid neoplasms, has authored 119 articles, 30 of them as the principal author, wi...
Beà, a researcher of the IDIBAPS group Molecular pathology in lymphoid neoplasms, has authored 119 articles, 30 of them as the principal author, wi...
Spanish investigators from the IDIBAPS-Hospital Clínic of Barcelona have led an international effort to develop an epigenetic clock that is able to...
People who have a haematological disease, such as lymphoma or leukaemia, present a state of immunosuppression caused both by the illness itself and...
In recent years, one of the strategies developed in the field of haematology is the modification of the patient’s immune system, also known as ‘imm...
The latest advance in the field of immune therapies against cancer are the active and targeted CAR therapies. This treatment consists of obtaining...